Posts tagged “liquidia”
This week Liquidia presented data from two preclinical studies at the annual meeting of the Association for Research in Vision and Ophtalmology, studies that offer a peek at ophtalmic applications Liquidia has been researching.
Nanotechnology company Liquidia plans to spin off a separate company. Read more about the therapeutic and financial opportunities Liquidia sees in eye drugs.
CED Life Science Conference 2013: Nanotechnology company Liquidia is considering spinning its research off into one, perhaps even two companies to pursue different targets utilizing its proprietary nanoparticle technology.
The Research Triangle Park-based firm is working with PATH to conduct preclinical studies on a "next generation" pneumococcal vaccine that could be more effective than existing vaccines and more efficient to produce.